Does Rallies show 13F holders for EVMN?

Yes. Rallies tracks hedge fund and 13F ownership data for EVMN, including fund names, share counts, latest tracked quarter, and position changes when available.

Is EVMN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for EVMN. It does not provide personalized investment advice.

EVMN (Evommune, Inc.) Stock Analysis - Hedge Fund Holdings

Evommune, Inc. (EVMN) is a publicly traded the market company. As of May 21, 2026, EVMN trades at $22.32 with a market cap of $788.44M and a P/E ratio of -1.95. EVMN moved +4.69% today. Year to date, EVMN is +44.96%; over the trailing twelve months it is flat. Its 52-week range spans $13.89 to $33.20. Analyst consensus is strong buy with an average price target of $52.00. Rallies surfaces EVMN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns EVMN stock?

Hedge funds tracked by Rallies that own EVMN include Exoduspoint Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Evommune, Inc..

EVMN Key Metrics

Key financial metrics for EVMN
Metric	Value
Price	$22.32
Market Cap	$788.44M
P/E Ratio	-1.95
EPS	$-11.22
Dividend Yield	0.00%
52-Week High	$33.20
52-Week Low	$13.89
Volume	174
Avg Volume	0
Revenue (TTM)	$13.00M
Net Income	$-68.87M
Gross Margin	0.00%

Top Hedge Funds Holding EVMN

Exoduspoint Capital holds 93.91K shares of EVMN, changed +0.00% as of Mar 31, 2026.

Latest EVMN News

Evommune's Phase 2a Success Drives $65 Price Target and $125M Funding — Feb 15, 2026
Evommune Shares Slip After 70% Rally Following 33% Eczema Trial Gain — Feb 12, 2026

Recent EVMN Insider Trades

Hopfner Robert Lorne bought 1.00K (~$17.35K) on Dec 19, 2025.
RA CAPITAL MANAGEMENT, L.P. bought 1.16M (~$18.51M) on Nov 7, 2025.
RA CAPITAL MANAGEMENT, L.P. bought 92.90K (~$1.49M) on Nov 7, 2025.

EVMN Analyst Consensus

8 analysts cover EVMN: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $52.00.

Common questions about EVMN

Who owns EVMN stock?: Hedge funds tracked by Rallies that own EVMN include Exoduspoint Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Evommune, Inc..
Does Rallies show 13F holders for EVMN?: Yes. Rallies tracks hedge fund and 13F ownership data for EVMN, including fund names, share counts, latest tracked quarter, and position changes when available.
Is EVMN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for EVMN. It does not provide personalized investment advice.